acute%20coronary%20syndromes%20w_out%20persistent%20st-segment%20elevation
ACUTE CORONARY SYNDROMES W/OUT PERSISTENT ST-SEGMENT ELEVATION
Acute coronary syndromes refer to any constellation of clinical symptoms compatible with acute myocardial ischemia which may be life-threatening.
It encompasses unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI).
Unstable angina is the ischemic discomfort that presents without persistent ST-segment elevation on ECG and without the presence of cardiac markers in the blood.
Non-ST-segment elevation myocardial infarction is diagnosed if cardiac markers are positive with ST-segment depression or with nonspecific or normal ECGs.
The patient typically presents with ischemic-type chest pain that is severe and prolonged and may occur at rest or may be caused by less exertion than previous episodes.

Acute Coronary Syndromes w/out Persistent ST-Segment Elevation Drug Information

Drug Information

Indication: HTN, vasospastic (Prinzmetal's or variant angina) or chronic stable angina.

Indication: 1st-line treatment of HTN & myocardial ischaemia. Monotherapy or in combination w/ other antianginal drugs...

Indication: HTN. 1st-line treatment of myocardial ischemia in fixed obstruction (stable angina) &/or vasoconstriction/...

Indication: 2.5 mg: Prevention of venous thromboembolic events (VTE) in patients undergoing major orthopaedic lower limbs ...

Indication: Management of HTN, angina pectoris, cardiac arrhythmias, MI.

Indication: 1st-line treatment for HTN as monotherapy or combination w/ other antihypertensive agents; myocardial ischemia...

Indication: HTN; angina pectoris; MI. Cardiac rhythm disturbances including supraventricular tachycardia. Functional heart...

Indication: HTN, CHD (angina pectoris), stable chronic heart failure w/ reduced systolic left ventricular function in addi...

Indication: 2.5 & 5 mg: Stable chronic heart failure w/ reduced systolic left ventricular function. 5 mg: HTN & CH...

Indication: Stable chronic heart failure w/ reduced systolic left ventricular function in addition to ACE inhibitors, diur...

2  /  16
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 20 Nov 2020
Metformin may improve vascular function in chronic kidney disease (CKD) patients with metabolic syndrome (MetS), according to a study presented at ASN Kidney Week 2020.